Domain-trained models can cut manual work by 80%, increase productivity by 75% and reduce false positives by 50% to take existing AI services to a higher level of performance. Princeton, New Jersey — RxLogix Corporation today announced the launch of PVOne.AI, the fourth-generation of the product that now includes Agentic AI capabilities designed to advance […]
We are pleased to announce that the European Medicines Agency (EMA) has successfully gone live on PV Signal and PV Reports, our industry-leading platform specifically supporting signal detection, analytics, and signal validation. With a safety database encompassing more than 35 million safety reports, EMA now operates one of the largest and advanced safety surveillance platforms powered by RxLogix technology. This implementation represents a major milestone, for EMA’s adopting next-generation […]
[Aventura, FL] – [8/1/2025] – RxLogix Corporation, a global leader in PV and drug safety solutions, proudly announces a groundbreaking achievement in collaboration with the U.S. Food and Drug Administration (FDA). Together, the teams have reached a significant milestone by successfully implementing a first-of-its-kind capability: running thousands of safety alerts across an entire product dictionary—spanning […]
Princeton, New Jersey, November 19, 2018 – RxLogix Corporation, a global leading provider of Safety and Pharmacovigilance (PV) Software and Services, today announced the signing of an agreement with Booz Allen Hamilton to support the implementation of PV Signal and PV Reports at the US Food and Drug Administration (FDA). The FDA is responsible for protecting […]
Princeton, New Jersey, November 10, 2021 – RxLogix Corporation, a global leading provider of end-to-end Safety and Pharmacovigilance (PV) Software and Services, today announced the Go-Live of FAERS II at the United States Food and Drug Administration (FDA). FAERS II utilizes the RxLogix integrated PV signaling platform consisting of PV Signal, PV Reports, and PV Analytics. […]
RxLogix provides the industry's best solutions to the ever-changing drug safety & pharmacovigilance
BOOK A DEMOSubscribe to our newsletter and learn the latest news from RxLogix.
Information on RxLogix Products – info@rxlogix.com
RFI and RFP Response Request – sales@rxlogix.com
Sales Inquiries – sales@rxlogix.com
Marketing Inquiries – marketing@rxlogix.com
Career Opportunities – careers@rxlogix.com
